Orexigen Therapeutics, Inc. (NASDAQ:OREX)
CAPS Rating:
A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity.
RSS Headlines
Fool UK
Recs
porto. likedded it.